A large study of 3.7 million children found that CT scans and other ionizing radiation medical imaging are associated with a dose-related increase in brain tumor risk, with a single head CT corresponding to approximately one excess brain tumor per 1,266 examinations. Researchers recommend careful clinical justification and dose minimization when using pediatric imaging with ionizing radiation.
- Study analyzed 3.7 million children over a mean follow-up of 12.3 years, identifying 1,536 brain tumor diagnoses
- Head CT scans delivered an average brain radiation dose of 66.2 mGy and were associated with a 1.8-fold increased brain tumor risk
- One head CT examination corresponded to 7.9 excess brain tumors per 10,000 children by age 21
- Risk increased with cumulative radiation dose across all imaging modalities, with stronger associations for aggressive tumor types
- Experts recommend clinical justification and dose optimization rather than automatic imaging thresholds, balancing diagnostic benefit against radiation exposure
CT scans and other ionizing medical imaging are associated with a dose-related increase in brain tumor risk among children and adolescents, according to a study published November 19 in JAMA.
The finding is from an analysis involving more than 3.7 million children over a mean follow-up period of 12.3 years, with findings supporting careful clinical justification and dose minimization when pediatric imaging using ionizing radiation is indicated, noted lead author Diana Miglioretti, PhD, of the University of California, Davis, and colleagues.
"The observed associations occurred at dose levels corresponding to commonly performed imaging examinations," the group wrote. "For example, head CT, the most common CT examination performed in children, had an average radiation dose to the brain of 66 mGy and was associated with a 1.8-fold increased risk of brain tumor."
Brain tumors are the second most common childhood cancer and the leading cause of cancer death among children and adolescents, the authors wrote. Children face heightened radiation sensitivity due to higher rates of cell division and longer life expectancy, they noted. Prior cohort studies from Europe and Australia have reported associations between pediatric CT and brain tumor risk, but focused on CT alone and reflected older imaging practices, the authors explained.
In this study, the researchers focused on cumulative exposure across the full range of medical imaging modalities using ionizing radiation. The group analyzed data from the Risk of Pediatric and Adolescent Cancer Associated With Medical Imaging (RIC) retrospective cohort, which enrolled children born between January 1996 through April 2016 in six integrated U.S. and Canadian health care systems.
Subjects were cancer-free at two years old, with follow-up through December 31, 2017, for U.S. children and through December 31, 2024, for Canadian children. The researchers estimated cumulative absorbed radiation doses to the brain, lagged by two years, across radiography, CT, fluoroscopy, angiography, and nuclear medicine. The primary outcome was incident brain tumor.
The cohort of more than 3.7 million children, followed for about 45.7 million person-years, yielded 1,536 brain tumor diagnoses. Cumulative dose was associated with overall brain tumor risk (excess relative risk per 100 mGy, 1.27; P < .001), and the associations were stronger for aggressive histologies. A head CT delivered a mean estimated brain dose of 66.2 mGy. By age 21 years, exposure equivalent to one head CT corresponded to 7.9 excess brain tumors per 10,000 children, or roughly one excess tumor per 1,266 head CT examinations, the researchers reported.
"Pediatric imaging using ionizing radiation can be lifesaving; however, the findings reinforce the importance of clinical justification and dose optimization. Despite substantial evidence supporting selective use of head CT in children, potentially avoidable imaging persists, while pediatric CT use has recently increased," the group wrote.
In an accompanying editorial Federica Persiani, Luca Boldrini, MD, PhD, and Ruggero De Maria, MD, of the Catholic University of the Sacred Heart in Rome, cautioned that the findings are model-based population estimates, not individualized risk predictions for a single examination, and that residual confounding by clinical indication cannot be ruled out.
"A cumulative exposure record may assist quality assurance but should not become an automatic threshold that delays a needed examination or a calculator that presents uncertain population estimates as individualized risk," they wrote.
The editorialists reinforced that for clinical practice, the standard remains straightforward: select the examination most likely to answer the clinical question, use ionizing radiation when its expected benefit justifies the exposure, and obtain the necessary information at the lowest dose compatible with adequate image quality.
The full study is available here.



















